It is also becoming clear that the traditionally-accepted VEGF–angiogenesis–tumor growth axis contains an additional essential mediator, innate immune cells; those myeloid cells facilitate neovascularization by providing MMPs required for activating angiogenic factors and tissue remodeling or by themselves producing VEGF [307]. The gene discussed is VEGFA; the disease is neoplasm.